ITI Pharma and Healthcare Fund

Regular Plan · IDCW Option · Sectoral / Thematic · Scheme code 149269

NAV₹18.2447as on 25 Sep 2026

Fund houseITI Mutual Fund

CategorySectoral / Thematic

Plan & optionRegular · IDCW Option

History4.8 years

Returns (%)

	1M	3M	6M	1Y	3Y	5Y	7Y	10Y	Launch
This scheme	0.03	8.06	22.40	9.84	17.26	—	—	—	12.93
Nifty 500 benchmark	0.87	4.31	2.15	5.20	12.49	11.41	—	—	15.49
Sectoral / Thematic category median	—	—	—	2.21	13.47	10.56	—	13.46	—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

	Volatility	Sharpe	Sortino	Beta	Alpha	Max fall	R²
This scheme	13.3%	0.81	1.15	0.82	3.65%	-18.5%	57.49
Nifty 500 benchmark	17.2%	0.35	0.47	—	—	-37.3%	—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 57 months this scheme and its benchmark share.

Growth of ₹100 since launch

Drawdown from peak (%)

Every one-year period it has lived through

Windows	Worst	Median	Best	Periods that lost money
189	-10.5%	13.5%	56.9%	26%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up capture	Down capture	Correlation	Tracking error	Information ratio	Treynor
103%	87%	0.76	10.6%	0.26	9.26

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 57 months this scheme and Nifty 500 share.

ITI Pharma and Healthcare Fund

Regular Plan · IDCW Option

Allocation

By asset

Equity	99.27%
Cash & Equivalents	0.73%

By market cap

Concentration

Number of stocks	37
Top 5 stocks	37.12%
Top 10 stocks	56.95%
Top 20 stocks	81.45%
Lines in the filing	38

Largest holding	12.58%
Largest sector	Pharmaceuticals & Biotechnology 72.83%
Effective stocks	20.6
Sectors held	5
Cash	0.73%

Effective stocks is what the concentration works out to: a fund holding 37 names but most of its money in a few behaves like a fund of 21. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology	72.83%
Healthcare Services	22.70%
Healthcare Equipment & Supplies	1.50%
Consumer Durables	1.25%
Chemicals & Petrochemicals	0.99%
Cash & Equivalents	0.73%

ITI Pharma and Healthcare Fund

Regular Plan · IDCW Option · holdings

Top 30 holdings

#	Company	Sector	Shares held	Value ₹ cr	% of fund
1	Sun Pharmaceutical Industries Limited	Pharmaceuticals & Biotechnology	175,147	35	12.58%
2	Divi's Laboratories Limited	Pharmaceuticals & Biotechnology	26,936	26	9.23%
3	Apollo Hospitals Enterprise Limited	Healthcare Services	17,745	16	5.72%
4	Max Healthcare Institute Limited	Healthcare Services	128,340	13	4.84%
5	Torrent Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	25,919	13	4.75%
6	Dr. Reddy's Laboratories Limited	Pharmaceuticals & Biotechnology	103,145	12	4.31%
7	Cipla Limited	Pharmaceuticals & Biotechnology	82,778	12	4.22%
8	Laurus Labs Limited	Pharmaceuticals & Biotechnology	58,017	11	4.02%
9	Aurobindo Pharma Limited	Pharmaceuticals & Biotechnology	63,858	11	3.97%
10	Mankind Pharma Limited	Pharmaceuticals & Biotechnology	37,842	9	3.31%
11	Neuland Laboratories Limited	Pharmaceuticals & Biotechnology	3,820	9	3.18%
12	Cohance Lifesciences Limited	Pharmaceuticals & Biotechnology	187,861	9	3.10%
13	Global Health Limited	Healthcare Services	55,636	8	2.98%
14	Alkem Laboratories Limited	Pharmaceuticals & Biotechnology	15,126	8	2.92%
15	Fortis Healthcare Limited	Healthcare Services	86,038	8	2.82%
16	Lupin Limited	Pharmaceuticals & Biotechnology	30,681	7	2.43%
17	Abbott India Limited	Pharmaceuticals & Biotechnology	2,101	5	1.97%
18	IPCA Laboratories Limited	Pharmaceuticals & Biotechnology	26,840	5	1.92%
19	Shilpa Medicare Limited	Pharmaceuticals & Biotechnology	46,264	4	1.59%
20	Sai Life Sciences Limited	Pharmaceuticals & Biotechnology	30,172	4	1.59%
21	Healthcare Global Enterprises Limited	Healthcare Services	58,542	4	1.55%
22	Poly Medicure Limited	Healthcare Equipment & Supplies	23,514	4	1.50%
23	Aster DM Quality Care Limited	Healthcare Services	53,546	4	1.47%
24	Piramal Pharma Limited	Pharmaceuticals & Biotechnology	170,152	4	1.32%
25	Shaily Engineering Plastics Limited	Consumer Durables	10,580	3	1.25%
26	Anthem Biosciences Limited	Pharmaceuticals & Biotechnology	38,631	3	1.25%
27	Glenmark Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	12,837	3	1.15%
28	Thyrocare Technologies Limited	Healthcare Services	48,000	3	1.05%
29	GlaxoSmithKline Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	9,213	3	1.02%
30	Linde India Limited	Chemicals & Petrochemicals	4,295	3	0.99%

ITI Pharma and Healthcare Fund

Regular Plan · IDCW Option · where the money sits

What the manager did last month

Between the filings of 31 Jul 2026 and 31 Aug 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

Bought	Sold	New positions	Sold out of	Price move of holdings
₹9 cr	₹2 cr	3	4	+3.77%

Stock	Shares traded	Shares	Price	Value ₹ cr
New position
Anthem Biosciences Limited	38,631	entered	—	3.5
Thyrocare Technologies Limited	48,000	entered	—	2.9
Metropolis Healthcare Limited	34,949	entered	—	2.0
Added to
Alkem Laboratories Limited	1,772	+13.3%	-7.3%	0.9
Divi's Laboratories Limited	946	+3.6%	+17.5%	0.9
IPCA Laboratories Limited	4,352	+19.4%	+13.0%	0.9
Healthcare Global Enterprises Limited	11,149	+23.5%	+9.3%	0.8
Max Healthcare Institute Limited	7,619	+6.3%	-5.1%	0.8
Aster DM Quality Care Limited	10,492	+24.4%	-8.1%	0.8
Fortis Healthcare Limited	8,567	+11.1%	-4.0%	0.8
Abbott India Limited	301	+16.7%	-7.0%	0.8
Trimmed
Neuland Laboratories Limited	365	-8.7%	+20.8%	0.8
Laurus Labs Limited	2,882	-4.7%	+5.4%	0.6
Shilpa Medicare Limited	3,304	-6.7%	+55.3%	0.3
Sold out of
MedPlus Health Services Limited	32,629	exited	—	2.3
Venus Pipes And Tubes Limited	10,960	exited	—	1.8
Bharat Dynamics Limited	9,895	exited	—	1.2
Yes Bank Limited	528,725	exited	—	1.2

Not equity	Previous filing	This filing	Change
Cash, repo and TREPS	₹0 cr	₹0 cr	+₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 27 Sep 2026.